Abstract
Insulin-like growth factor-1 (IGF-1) is a hormone that is important in the regulation of growth processes and additionally has been demonstrated to modulate metabolic and autonomic responses. Some of its effects are mediated by the central nervous system (CNS), and there are IGF-1 receptors dispersed throughout the CNS. Both IGF-1 and insulin alter peripheral metabolic and autonomic nervous activity by a central mechanism, and the well-defined role of insulin in the regulation of feeding, especially in diabetes, led us to investigate the effect of chronic central administration of IGf-1 on metabolic and feeding parameters in normal and diabetic rats. Normal and diabetic rats with intracere-broventricular cannulas were given IGF-1, insulin (0.5 nmol/animal), or artificial cerebrospinal fluid via cannula twice daily for 4 d. Blood samples were collected on d 2 and 4, and the body weights and food intake were recorded daily. IGF-1 administered intracere-breventricularly did not alter plasma glucose, insulin, body weight, or food intake in normal rats. However, in diabetic animals, IGF-1 decreased food intake but did not alter blood glucose or plasma insulin. In correlated studies, intracerebroventricular insulin decreased food intake in both normal and diabetic animals. From these studies, we conclude that IGF-1 may act centrally to decrease food intake in the hyperphagic diabetic animals but not in normal animals. This suggests that diabetic animals have an increased sensitivity to CNS IGF-1.
Similar content being viewed by others
References
Werther, G. A., Russo, V., Baker, N., and Butler, G. (1998). Horm. Res. 49, 37–40.
Skottner, A., Clark, R. G., Fryklund, L., and Robinson, I. C. (1989). Endocrinology 124, 2519–2526.
Sara, V. R., Hall, K., Von Holtz, H., Humbel, R., Sjogren, B., and Wetterberg, L. (1982). Neurosci. Lett. 34, 39–44.
Kadowaki, T., Tobe, K., Honda-Yamamoto, R., Tamemoto, H., Yamauchi, T., Akanuma, Y., and Yazaki, Y. (1996). Endocrine J. 43, S33-S41.
Treadway, J. L., Morrison, B. D., Godfine, I. D., and Pessin, J. E. (1989). J. Biol. Chem. 264, 21,450–21,453.
Sahu, A., Dube, M. G., Phelps, C. P., Sninsky, C. A., Kalra, P. S., and Kalra, S. P. (1995). Endocrinology 136, 5718–5724.
Woods, S. C., Lotter, E. C., McKay, L. D., and Porte, D. Jr. (1979). Nature 282, 503–505.
Hileman, S. M., Schillo, K. K. and Hall, J. B. (1993). Biol. Reprod. 48, 117–124.
McGowan, M. K., Andrews, K. M., and Grossman, S. P. (1992). Physiol. Behav. 51, 753–766.
Lu, H., Duanmu, Z., Scislo, T., and Dunbar, J. C. (1998). Clin. Exp. Hyperten. 20, 165–183.
Hu, Y., Pete, G., Walsh, M. F., Sowers, J., and Dunbar, J. C. (1996). Horm. Metab. Res. 28, 211–214.
Pete, G. and Dunbar, J. C. (1998). Clin. Exp. Hypertens. 20, 67–83
Sipols, A. J., Baskin, D. G., and Schwartz, M. W. (1995). Diabetes 44, 147–151.
Foster, L. A., Ames, N. K., and Emery, R. S. (1991). Physiol. Behav. 50, 745–749.
Tannenbaum, G. S., Guyda, H. J., and Posner, B. I. (1983). Science 220, 77–79.
Manin, M., Balage, M., Larue-Achagiotis, C., and Grizard, J. (1988). J. neurochem. 51, 1689–1695.
Mynarcik, D. C., Williams, P. F., Schaffer, L., Yu, G. Q., and Whittaker, J. (1997). J. Biol. Chem. 272, 18,650–18,655.
Baskin, D. G., Sipols, A. J., Schwartz, M. W., and White, M. F. (1993). Regul. Pep. 48, 257–266.
White, J. D., Olchovsky, D., Kenshaw, M., and Berelowitz, M. (1990). Endocrinology 126, 765–772.
Schwartz, M. W., Sipols, A. J., Marks, J. L., Sanacora, G., White, J. D., Scheurink, A., Kahn, S. E., Baskin, D. G., Woods, S. C., and Figlewicz, D. P. (1992). Endocrinology 130, 3608–3616.
Acerini, C. L., Harris, D. A., Matyka, K. A., Watts, A. P., Umpleby, A. M., Russell-Jones, C. L., and Dunger, D. B. (1998). Metabolism 47, 1481–1489.
Thrailkill, K. M., Quattrin, T., Baker, L., Kuntze, J. E., Compton, P. G., and Martha, P. M. Jr. (1999). Diabetes Care 22, 585–592.
Adem, A., Jossan, S. S., d'Argy, R., Gillberg, P. G., Nordgery, A., Winblad, B., and Sara, V. (1989). Brain Res. 503, 299–303.
Duanmu, Z., Lapanowski, K., and Dunbar, J. C. (1997). Proc. Soc. Exp. Biol. Med. 216, 93–97.
Bohannon, N. J., Corp, E. S., Wilcox, B. J., Figlewicz, D. P., Dorsa, D. M., and Baskin, D. G. (1988). Endocrinology 122, 1940–1947.
Lauterio, T. J., Marson, L., Daughaday, W. H., and Baile, C. A. (1987). Physiol. Behav. 40, 755–758.
Harel, Z. and Tannenbaum, G. S. (1992). Neuroendocrinology 56, 161–168.
Reul, B. A., Ongemba, L. N., Pattier, A. M., Henquin, J. C., and Brichard, S. M. (1997). Biochem. J. 324, 605–610.
Harel, Z. and Tannenbaum, G. S. (1992). Endocrinology 131, 758–764.
Boni-Schnetzler, M., Haori, C., and Zapf, J. (1999). Diabetologica 42, 160–166.
Schultz-Klarr, S., Wright-Richey, J., and Dunbar, J. C. (1994). JAAMP 5, 152–158.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lu, H., Martinez-Nieves, B., Lapanowski, K. et al. Intracerebroventricular insulin-like growth factor-1 decreases feeding in diabetic rats. Endocr 14, 349–352 (2001). https://doi.org/10.1385/ENDO:14:3:349
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:14:3:349